E2 ModerateModerate confidencePEM unclearCase-ControlPeer-reviewedMachine draft
Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome and with illness following organophosphate exposure.
Khan, Faisel, Kennedy, Gwen, Spence, Vance A et al. · Clinical science (London, England : 1979) · 2004 · DOI
Quick Summary
Researchers tested how blood vessels in the forearm respond to acetylcholine (a chemical messenger in the body) in people with ME/CFS, Gulf War illness, and pesticide exposure. They found that people with ME/CFS had an unusually strong vascular response to acetylcholine, but people with the other two conditions had normal responses. This suggests ME/CFS may involve a specific problem with how the body breaks down acetylcholine in blood vessels.
Why It Matters
This study provides objective physiological evidence of a specific biological abnormality in ME/CFS affecting how blood vessels process acetylcholine, distinguishing it mechanistically from similar-appearing conditions. Understanding this vascular cholinergic dysfunction could eventually lead to targeted diagnostic tests and novel therapeutic approaches for ME/CFS patients.
Observed Findings
- Acetylcholine response was significantly higher in CFS patients compared to healthy controls (P=0.029)
- In CFS patients, acetylcholine and methacholine responses were not significantly different from each other
- In GWS and organophosphate-exposed groups, acetylcholine responses were normal and methacholine responses exceeded acetylcholine responses
- The vascular cholinergic abnormality appeared specific to ME/CFS despite clinical similarities between the three illness groups
Inferred Conclusions
- ME/CFS involves a distinct peripheral cholinergic abnormality affecting vascular endothelium, likely involving reduced cholinesterase activity
- This abnormality differs fundamentally from those in Gulf War syndrome and organophosphate-related illness, suggesting different disease mechanisms
- Vascular cholinesterase inhibition may be a key pathophysiological feature distinguishing ME/CFS from other post-exposure or post-infectious illnesses
Remaining Questions
- What causes the cholinesterase inhibition specifically in ME/CFS, and is it primary or secondary to other disease processes?
- Does this peripheral vascular abnormality correlate with symptom severity or specific symptom clusters in ME/CFS?
What This Study Does Not Prove
This study demonstrates an association between cholinesterase activity and ME/CFS but does not establish whether this abnormality causes ME/CFS symptoms or results from the disease process. The small sample size and cross-sectional design mean findings require replication, and the study cannot determine whether this peripheral vascular abnormality reflects broader systemic cholinergic dysfunction.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall Sample
Metadata
- DOI
- 10.1042/CS20030246
- PMID
- 14503920
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →